- Home
- KROS vs NAT Comparison
KROS vs NAT Comparison
Compare KROS & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NAT
- Stock Information
- Founded
- KROS 2015
- NAT 1995
- Country
- KROS United States
- NAT Bermuda
- Employees
- KROS N/A
- NAT N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NAT Marine Transportation
- Sector
- KROS Health Care
- NAT Consumer Discretionary
- Exchange
- KROS Nasdaq
- NAT Nasdaq
- Market Cap
- KROS 565.0M
- NAT 675.5M
- IPO Year
- KROS 2020
- NAT 1997
- Fundamental
- Price
- KROS $15.66
- NAT $3.17
- Analyst Decision
- KROS Buy
- NAT Hold
- Analyst Count
- KROS 14
- NAT 1
- Target Price
- KROS $20.56
- NAT $3.00
- AVG Volume (30 Days)
- KROS 430.7K
- NAT 2.0M
- Earning Date
- KROS 11-05-2025
- NAT 08-28-2025
- Dividend Yield
- KROS N/A
- NAT 10.76%
- EPS Growth
- KROS N/A
- NAT N/A
- EPS
- KROS 0.47
- NAT 0.06
- Revenue
- KROS $232,844,000.00
- NAT $301,169,000.00
- Revenue This Year
- KROS $5,579.44
- NAT N/A
- Revenue Next Year
- KROS N/A
- NAT $37.34
- P/E Ratio
- KROS $33.65
- NAT $51.74
- Revenue Growth
- KROS 85820.30
- NAT N/A
- 52 Week Low
- KROS $9.12
- NAT $2.13
- 52 Week High
- KROS $72.37
- NAT $3.83
- Technical
- Relative Strength Index (RSI)
- KROS 59.38
- NAT 58.57
- Support Level
- KROS $15.23
- NAT $3.15
- Resistance Level
- KROS $15.85
- NAT $3.28
- Average True Range (ATR)
- KROS 0.52
- NAT 0.09
- MACD
- KROS 0.01
- NAT 0.00
- Stochastic Oscillator
- KROS 72.91
- NAT 56.94
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.